Novel MRI Biomarkers for Monitoring Disease Progression in ALS | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Novel MRI Biomarkers for Monitoring Disease Progression in ALS	Nutritional and Metabolic Diseases, TDP-43 proteinopathy, amyotrophic lateral sclerosis, central nervous system disorder, metabolic disease, motor neuron disorder, nervous system disorder, neurodegenerative disease, neuromuscular disease, proteostasis deficiencies, spinal cord disorder	Active, not recruiting	Not stated	2026-05-08		NCT03362658

9 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Laval University	96
McGill University	81
University of Alberta	249
University of British Columbia	284
University of Calgary	238
University of Miami	277
University of Toronto	140
University of Utah	319
Western University, Canada	70

7 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Laval University	Québec	Canada	6
McGill University / Montreal Neurological Institute and Hospital	Montreal	Canada	1
University of Alberta	Edmonton	Canada	10
University of Calgary / Heritage Medical Research Clinic	Calgary	Canada	1
University of Miami	Miami	United States	6
University of Toronto / Sunnybrook Health Sciences Centre	Toronto	Canada	2
University of Utah	Salt Lake City	United States	72